ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.32
+1.60 (6.75%)
At close: Jun 26, 2026, 4:00 PM EDT
25.25
-0.07 (-0.28%)
After-hours: Jun 26, 2026, 7:31 PM EDT
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for ACADIA Pharmaceuticals stock have an average target of 32.6, with a low estimate of 23 and a high estimate of 40. The average target predicts an increase of 28.75% from the current stock price of 25.32.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $37 | Buy | Maintains | $37 | +46.13% | Jun 26, 2026 |
| Oppenheimer | Oppenheimer | Hold Maintains $23 | Hold | Maintains | $23 | -9.16% | May 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $34 | Buy | Maintains | $34 | +34.28% | May 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 8, 2026 |
| Citi | Citi | Buy Maintains $33 → $32 | Buy | Maintains | $33 → $32 | +26.38% | May 8, 2026 |
Financial Forecast
Revenue This Year
1.24B
from 1.07B
Increased by 15.83%
Revenue Next Year
1.39B
from 1.24B
Increased by 11.78%
EPS This Year
0.40
from 0.83
Decreased by -52.13%
EPS Next Year
0.90
from 0.40
Increased by 125.38%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | 1.5B | |
| Avg | 1.2B | 1.4B | |
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.9% | 18.1% | |
| Avg | 15.8% | 11.8% | |
| Low | 14.2% | 1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.74 | 1.70 | |
| Avg | 0.40 | 0.90 | |
| Low | 0.23 | 0.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -10.8% | 328.0% | |
| Avg | -52.1% | 125.4% | |
| Low | -72.3% | 25.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.